These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2653752)

  • 21. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM--the clinical characteristics and pathogenesis of the syndrome.
    Kobayashi T
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S95-9. PubMed ID: 7859641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families.
    Lipton RB; Atchison J; Dorman JS; Duquesnoy RJ; Eckenrode K; Orchard TJ; LaPorte RE; Riley WJ; Kuller LH; Drash AL
    Diabet Med; 1992 Apr; 9(3):224-32. PubMed ID: 1576803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
    Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
    Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
    Hsieh SD; Kanazawa Y; Akanuma Y
    Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
    Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
    Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
    Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
    Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of islet cell antibodies by using avidin-biotin-peroxidase complex technique].
    Yang JL; Huang YQ; Yue Y
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):92-4. PubMed ID: 8070298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
    Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose and insulin responses to oral glucose in overt non-insulin-dependent diabetics with and without the islet cell antibody.
    Gray RS; Irvine WJ; Cameron EH; Duncan LJ
    Diabetes; 1980 Apr; 29(4):312-6. PubMed ID: 6987121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of anti-DNA antibody in diabetes mellitus: its relation to the duration of diabetes and diabetic complications.
    Yokokawa N; Aizawa T; Ishihara M; Koizumi Y; Yanagisawa K; Yamada T
    Metabolism; 1989 Sep; 38(9):891-4. PubMed ID: 2671600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
    Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet cell surface antibodies in diabetes and their possible influence on glucose tolerance.
    Ohgawara H; Hirata Y
    Tohoku J Exp Med; 1984 Feb; 142(2):211-6. PubMed ID: 6372161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.